NCT06252194

Comparative Study of Metformin Versus Doxycycline in Moderate to Severe Adult Acne Vulgaris Patients.

Name: Clinical Trial NCT06252194
Creator: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Keywords: Acne Vulgaris, Metformin and doxycycline, Phase 2, drug, clinical trial, Bangladesh

Comparative Study of Metformin Versus Doxycycline in Treatment of Moderate to Severe Adult Acne Vulgaris Patients: Multicentre, Randomized, Double-blind Trial.

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh·Phase 2·ClinicalTrials.gov·drugRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Acne Vulgaris
Drug/Device/Intervention: Metformin and doxycycline
Study type: Interventional
Intervention type: drug

Sponsor & location

Primary sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Location: Dhaka, Bangladesh

Timeline & enrollment

Phase: Phase 2
Start date: Mar 05, 2023
End date: Mar 01, 2024
Enrollment: 120 participants

Primary outcome

Global Acne Grading System (GAGS) Score

Summary

The goal of this clinical trial is to compare the effect of doxycycline and metformin in treatment of acne vulgaris patients. The main question is aimed to answer is whether metformin is more effective than doxycycline in treatment of acne vulgaris patient or not.  Patients will be asked to take doxycycline along with tropical treatment in one group and metformin along with tropical treatment in another group.  Researcher will compare the clinical improvement in two groups.

ICD-10 classifications

Acne vulgarisAcneAcne, unspecifiedAcné excoriéeOther acne

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06252194
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06252194 through Pure Global AI's free database. This Phase 2 trial is sponsored by Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh and is currently Recruiting. The study focuses on Acne Vulgaris. Target enrollment is 120 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.